Stratagen Bio
PrivateLast Round
Seed
Oct 18, 2024
Total Funding Raised
$475,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Stratagen Bio is a medical devices and equipment company that develops oxygen-sensing technology to incorporate direct and absolute measurements of tissue oxygen in the treatment planning process for applications in cancer, trauma, ischemic injuries, and vascular disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Sensors, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stratagen Bio Comparables
Compare Stratagen Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clin-EPR, LLC | 71% | |
| Profusa, Inc. | 65% | |
| Oxford Optronix | 64% |
Stratagen Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 18, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Sep 14, 2023 |
Stratagen Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Bertarelli Foundation | Grant |
| Everywhere Ventures | Seed, Pre Seed |
| Impact First | Seed |
| January Ventures | Seed |
| Alumni Ventures | Seed, Pre Seed |
| Looking Glass Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 116% MoM.
- Apr 15, 2026
Monthly visitors increased 268% MoM.
Stratagen Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stratagen Bio's valuation, stock price, and market status.
Is Stratagen Bio a public or private company?
Stratagen Bio is a private company.
What is the current stock price of Stratagen Bio?
Stratagen Bio is a private company, so its shares have no public market price. Caplight tracks Stratagen Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stratagen Bio worth (valuation)?
Valuation information for Stratagen Bio is not publicly available.
Can I buy Stratagen Bio stock?
Stratagen Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stratagen Bio's last funding round?
Stratagen Bio's most recent funding round was Seed on October 18, 2024.
Who are the main investors in Stratagen Bio?
Key investors in Stratagen Bio include National Cancer Institute, Bertarelli Foundation, Everywhere Ventures, Impact First, January Ventures.
Will Stratagen Bio IPO soon?
No public IPO plans have been announced for Stratagen Bio.
How can I track Stratagen Bio secondary market activity?
Caplight tracks bids, offers, and trades in Stratagen Bio's shares on secondary markets.